SCHEMBL17690053

SCHEMBL17690053

C=C(O[PH](=O)O)c1cc2c(o1)C(=O)c1ccccc1C2=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 7/20 0.56
▸ ALDH1A1 P00352 4/20 0.56
▸ BCL2 P10415 3/20 0.34
▸ MCL1 Q07820 3/20 0.34
▸ MAPT P10636 5/20 0.34
▸ KMT2A Q03164 5/20 0.34
▸ HTT P42858 2/20 0.34
▸ APAF1 O14727 2/20 0.34
▸ MITF O75030 2/20 0.34
▸ LMNA P02545 2/20 0.34
▸ RAB9A P51151 2/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ MEN1 O00255 4/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ CDC25B P30305 1/20 0.33
▸ USP1 O94782 1/20 0.33
▸ USP19 O94966 1/20 0.33
▸ WDR48 Q8TAF3 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ TTR P02766 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12960697 0.78 STAT3 (0.56) STAT3ALDH1A1BCL2MCL1MAPT
SCHEMBL16917433 0.76 STAT3 (0.76) STAT3ALDH1A1BCL2MCL1MAPT
SCHEMBL19820871 0.76 STAT3 (0.57) STAT3ALDH1A1BCL2MCL1MAPT
SCHEMBL12960696 0.75 ALDH1A1 (0.56) STAT3ALDH1A1MAPTKMT2AHTT
Napabucasin SCHEMBL29349770 0.72 STAT3 (1.00) STAT3ALDH1A1BCL2MCL1MAPT
SCHEMBL12640087 0.72 STAT3 (0.75) STAT3ALDH1A1BCL2MCL1MAPT
Napabucasin SCHEMBL1883845 0.72 STAT3 (1.00) STAT3ALDH1A1BCL2MCL1MAPT
SCHEMBL18691843 0.71 STAT3 (0.73) STAT3ALDH1A1BCL2MCL1MAPT
SCHEMBL12640086 0.71 STAT3 (0.73) STAT3ALDH1A1BCL2MCL1MAPT
SCHEMBL19824423 0.70 STAT3 (0.49) STAT3ALDH1A1MAPTKMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3050566-A2 A NOVEL GROUP OF STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL PATHWAY INHIBITORS Boston Biomedical, Inc. (US) 2016-08-03 — — EP disclosed
EP-2190429-B1 A NOVEL GROUP OF STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL PATHWAY INHIBITORS BOSTON BIOMEDICAL INC (US) 2016-04-20 — — EP disclosed
Send feedback